Posted on 20th November 2011
Scientists in in Australia have just completed a study involving 10,000 patients aged between 50 and 75. Patients taking the drug, fenofibrate, were found to reduce their risk of needing laser treatment (a normal treatment diabetic eye disease) by a third. Fenofibrate is a lipid-modifying agent that helps to reduce complications in diabetic retinopathy. Professor Ian Young from Queen’s University, Belfast who lead the study has urged the National Institute for Clinical Excellence (NICE) to recommend using the drug in the NHS.
22nd April 2021
After a year like no other, we are especially impressed by our optometrist, Rebecca Daly, who is one of the first individuals to have gained the NHS Education for Scotland Glaucoma Award Training (NES...Read more
14th April 2021
Myopia is expected to affect 50% of the world population by 2050. In the UK, the amount of myopia has increased from 10% to 23% of children in the past 50 years. In the past year, we have noticed an i...Read more